Tag: TCR therapies

Krakow, Poland, 04.11.2021. Ardigen, one of the world’s leading companies that utilizes artificial intelligence (AI) algorithms for drug discovery, announced that another distinguished scientist joined the company’s Scientific Advisory Board. Prof. Olivera Finn will support Ardigen’s work on AI-driven technology […]

Ardigen received funding for development of AI-powered Microbiome Platform that will improve prediction of cancer therapies efficacy. Krakow, Poland, 25.10.2021. Ardigen- the world-leading company that utilizes Artificial Intelligence (AI) for drug discovery, has signed an agreement with the Polish National […]

September 7, 2021 – Ardigen, one of the world-leading companies that utilizes artificial intelligence (AI) algorithms for drug discovery, is proud to announce that Dr. Aleksandra Walczak joined the company’s Scientific Council. With a PhD in physical sciences and her […]